Development of Exogenous Insulin Antibody Syndrome in a Patient with Newly Diagnosed Type 1 Diabetes Successfully Treated with Oral Immunosuppressive Monotherapy

Exogenous insulin antibody syndrome (EIAS), which rarely occurs in the patient with type 1 diabetes, results in antibody-induced insulin resistance, hyperglycemia, ketosis, ketoacidosis, and hypoglycemia when insulin is released from the saturated insulin antibodies. Recommended treatment regimens i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jerkins, Terri, Bell, David S. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479014/
https://www.ncbi.nlm.nih.gov/pubmed/34403116
http://dx.doi.org/10.1007/s13300-021-01129-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479014/
https://www.ncbi.nlm.nih.gov/pubmed/34403116
http://dx.doi.org/10.1007/s13300-021-01129-4

Ejemplares similares